Personal tools

ENPRA Workshop - Program with links to presentations

Joint JRC Nano event and 2nd ENPRA Stakeholders Workshop, 10-12 May 2011 - "Challenges of Regulation and Risk Assessment of Nanomaterials"

Twenty-eight presentations are offered below (click on the titles to get the pdf icon pdf version).

 

Enpra

Tuesday, 10 May 2011



Opening Chair: Elke Anklam, European Commission (JRC)


Welcome and Introduction [A. Riedl, JRC]


Objectives and organization of the workshop [J. Riego Sintes, JRC]

 




1st SESSION: REGULATORY DEVELOPMENT

CHAIR: B. Sokull-Kluettgen, European Commission (JRC)


EU Perspective [A. Kobe, DG ENV]

Nanomaterials in REACH registration and C&L notification [B. Quinn, ECHA]

Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain [D. Carlander, EFSA]

Regulation and assessment of nanoscale materials under the Toxic Substances Control Act [J. Alwood, US-EPA]

Current progress of activities and efforts on nanomaterials environmental health and safety in China [C. Chen, National Center for Nanoscience and Technology, China]

PLENARY DISCUSSION

2nd SESSION: REGULATORY IMPLEMENTATION

CHAIR: F. Christensen, European Commission (JRC)


OECD Working Party on Manufactured Nanomaterials (WPMN)  [K. Rasmussen, JRC]

REACH Implementation Project on Nanomaterials: RIP-oN2: Information requirements [S. Hankin, IOM]

REACH Implementation Project on Nanomaterials: RIP-oN3: specific advice on exposure assessment and hazard/risk characterization for nanomaterials under REACH [R.  Aitken,IOM]

NANEX: development of Exposure Scenarios for manufactured nanomaterials [M. Van Tongeren, IOM]

Industry experience with conducting nanomaterial safety assessments [S. Friedrichs, NIA]

Life Cycle Assessment of nanomaterials in polymer nanocomposites [S. Vasquez, LEITAT]

Health, Safety and Environment: assessment methods [D. Hristozov, Università Ca' Foscari di Venezia]

The European Repository of nanomaterials and the NANOHub information platform [H. Rauscher, JRC]


PLENARY DISCUSSION

 

Wednesday, 11 May 2011

 

3rd SESSION: CHARACTERISATION AND DETECTION OF NANOMATERIALS

CHAIR: H. Rauscher, European Commission (JRC)


An example of the advantages and disadvantages related to producing a protocol database for nanoscience  [I. Gosens, RIVM]

Primary and secondary characterization of ENPRA ENP [K.A. Jensen, NRCWE]

Characterizations and detection in environmental media [M. Hassellov, Göteborgs Universitet]

 
PLENARY DISCUSSION

4th SESSION: EXPOSURE ASSESSMENT

CHAIR: Martie Van Tongeren (IOM)


Sources and Release: exposure to nanofilm sprays [K. A. Jensen, NRCWE]

Application and adaptation of exposure models [D. Brouwer, TNO]


PLENARY DISCUSSION

5th SESSION: ECOTOXICOLOGY & ENVIRONMENTAL FATE

CHAIR: T. Fernandes (HERIOT-WATT UNIVERSITY)


Introduction: content and goal of session

Challenges in managing ecological risks posed by nanomaterial: the balance between uncertainties and certitudes [L. Kaputska, SLR Consulting Ltd, Canada]

Integrating testing strategies for ecotoxicity assessment [K. Hund-Rinke, Fraunhofer-IME]

Ageing and toxicity of real NM in aquatic environment [J. Rose, CEREGE]

Comparing the reproductive toxicity of ZnO nanoparticles, bulk ZnO , and ZnCl2 to the earthworm Eisenia Andrei [D. Spurgeon, CEH]

The bioavalability and trophic transfer of manufactured nanomaterials in aquatic and terrestrial food webs: Research challenges and potential risks [P. M. Bertsch, University of Kentucky, USA]

Aquatic toxicity on fish: chronic studies, sub-lethal effects [T. Henry, University of Plymouth]

PLENARY DISCUSSION

 

Thursday, 12 May 2011


 

6th SESSION: HUMAN TOXICITY

CHAIR: Lang Tran, IOM


Challenges in nanomaterials human health risk assessment [K. Aschberger, JRC]

Exploring the genotoxic potential of engineered nanomaterials [L. Gonzalez, Vrje Universiteit Brussel]

Variation in acute toxicity for 9 engineered nanoparticles in murine lungs [ I. Gosens, RIVM]

Assessing the toxicological impact of a panel of engineered nanomaterials for risk assessment purposes [V. Stone, Heriot-Watt University]

Biokinetics of manufactured nanomaterials in vivo  [W. Kreyling, Helmholtz Zentrum]
Document Actions